Here we present viewpoints of experts from around the world on aspects relevant for the care of middle-life or older patients with MS, or other clinically vulnerable patients with the disease.
References
- BETAFERON® European Summary of Product Characteristics, October 2020. Available at: https://www.ema.europa.eu/en/documents/product-information/betaferon-epar-product-information_en.pdf. Accessed on: February 3, 2022. Return to content
- Duszczyszyn DA et al. J Neuroimmunol 2010; 221(1-2): 73-80. Return to content
- Gomez CR et al. Exp Gerontol 2008: 43(8): 718-28. Return to content
- Kasper LH, Reder AT. Ann Clin Transl Neurol 2014; 1(8): 622-31. Return to content
- Lord JM. Hum Vaccin Immunother 2013; 9(6): 1364-7. Return to content
- Mills EA, Mao-Draayer Y. Mult Scler 2018; 24(8): 1014-22. Return to content
- Musella A et al. Front Aging Neurosci 2018; 10: 238. Return to content
- Schweitzer F et al. Curr Opin Neurol 2019; 32(3): 305-12. Return to content
- Grebenciucova E, Berger JR. Curr Neurol Neurosci Rep 2017; 17(8): 61. Return to content
- Kollmann TR et al. Immunity 2012; 37(5): 771-83. Return to content
- Salminen A. J Mol Med (Berl) 2021; 99(11): 1553-69. Return to content
- Simon AK et al. Proc Biol Sci 2015; 282(1821): 20143085. Return to content
- Sun D et al. Cell Stem Cell 2014; 14(5): 673-88. Return to content
- Weideman AM et al. Front Neurol 2017; 8: 577. Return to content
- Wiendl H et al. Ther Adv Neurol Disord 2021; 14: 17562864211039648. Return to content
- Vaughn CB et al. Nat Rev Neurol 2019; 15(6): 329-42. Return to content
- Jakimovski D et al. Eur J Neurol 2019; 26(1): 87-e8. Return to content
- Kowalec K et al. Neurology 2017; 89(24): 2455-61. Return to content
- Magyari M, Sorensen PS. Front Neurol 2020; 11: 851. Return to content
- Marrie RA et al. Neurology 2009 Jan 13; 72(2): 117-24. Return to content
- Marrie RA al. Neurology 2010; 74(13): 1041-7. Return to content
- Marrie RA et al. Neurology 2015; 85(3): 240-7. Return to content
- Marrie RA et al. Mult Scler Relat Disord 2020; 40: 101987. Return to content
- Yadav V. Multiple Sclerosis Centers of Excellence of the U.S. Department of Veteran Affairs. Available at: https://www.va.gov/MS/Veterans/research/Vascular_Disease_Risk_Factors_and_Multiple_Sclerosis.asp Accessed on: February 3, 2022. Return to content
- Yamout B et al. Mult Scler Relat Disord 2020; 37: 101459. Return to content
- Zhang T et al. Neurology 2016; 86(14): 1287-95. Return to content
- Zhang T et al. Neurology 2018; 90(5): e419-27. Return to content
- Kister I et al. J Neurol Neurosurg Psychiatry 2016; 87(10): 1133-7. Erratum in: J Neurol Neurosurg Psychiatry 2019; 90(4): e2. Return to content
- Montalban X et al. Mult Scler 2018; 24(2): 96-120. Return to content
- Baecher-Allan C et al. Neuron 2018; 97(4): 742-68. Return to content
- Dendrou CA et al. Nat Rev Immunol 2015; 15(9): 545-58. Return to content
- Feng X et al. J Neuroimmunol 2002; 129(1-2): 205-15. Return to content
- Feng X et al. EBioMedicine 2019; 49: 269-83. Return to content
- Filippi M et al. Neurology 2011; 76(14): 1222-8. Return to content
- Kieseier BC. CNS Drugs 2011; 25(6): 491-502. Return to content
- Wiendl H, Kieseier BC. Expert Opin Investig Drugs 2003; 12(4): 689-712. Return to content
